Уноси

• Dejstvo furosemida, acetilsalicilne kiseline i deksametazona na ekskretornu funkciju bubrega (1997)

  S. Stoisavljević-Šatara, J. Nikolić, R. Škrbić, D. Babić-Đurić, Dejstvo furosemida, acetilsalicilne kiseline i deksametazona na ekskretornu funkciju bubrega, SCRIPTA MEDICA, Vol. 28, No. 2, pp. 57 - 62, 1997

• Uloga humanitarne pomoći na upotrebu analgetika i nesteroidnih antiinflamatornih lijekova u Kliničkom centru Banja Luka u ratnom i poslijeratnom periodu (2000)

  D. Babić-Đurić, S. Stoisavljević-Šatara, R. Škrbić, Uloga humanitarne pomoći na upotrebu analgetika i nesteroidnih antiinflamatornih lijekova u Kliničkom centru Banja Luka u ratnom i poslijeratnom periodu, SCRIPTA MEDICA, Vol. 31, No. 1, pp. 33 - 41, 2000

• Glycosidase activitis in hog serum, optic nerve, and ocular tissues (2004)

  L. Stojiljković, B. Alexander, S. Stoisavljević-Šatara, R. Škrbić, R. Igić, Glycosidase activitis in hog serum, optic nerve, and ocular tissues, BIOMEDICAL RESEARCH-TOKYO, Vol. 25, No. 2, pp. 101 - 103, 2004

• Effect of simvastatin on proinflammatory cytokines production in rats during lipopolysaccharide-induced inflammation (2009)

  L. Nežić, R. Škrbić, S. Dobrić, M. Stojiljković, Z. Milovanović, S. Stoisavljević-Šatara, N. Stojaković, Effect of simvastatin on proinflammatory cytokines production in rats during lipopolysaccharide-induced inflammation, GENERAL PHYSIOLOGY AND BIOPHYSICS, No. Special 28, pp. 119 - 126, 2009

• Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation (2009)

  L. Nežić, R. Škrbić, S. Dobrić, M. Stojiljković, V. Jačević, S. Stoisavljević-Šatara, Z. Milovanović, N. Stojaković, Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation, Basic Clin Pharmacol Toxicol, Vol. 104, No. 3, pp. 185 - 191, 2009

• The pharmaceutical sector in the Republic of Srpska, Bosnia and Herzegovina (2009-01)

  V. Marković Peković, R. Škrbić, N. Grubiša, The pharmaceutical sector in the Republic of Srpska, Bosnia and Herzegovina, Eurohealth, Vol. 15, No. 1, pp. 23 - 26, Jan, 2009

• Utilization of cardiovascular medicines in Republic of Srpska, Bosnia and Herzegovina, 5 years study (2009-04)

  V. Marković Peković, S. Stoisavljević-Šatara, R. Škrbić, Utilization of cardiovascular medicines in Republic of Srpska, Bosnia and Herzegovina, 5 years study, PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 18, No. 4, pp. 320 - 326, Apr, 2009

• Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia and Herzegovina (2010-02)

  V. Marković Peković, S. Stoisavljević-Šatara, R. Škrbić, Outpatient utilization of drugs acting on nervous system: a study from the Republic of Srpska, Bosnia and Herzegovina, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, Vol. 66, No. 2, pp. 177 - 186, Feb, 2010

• Simvastatin improves survival and reduces leukocyte recruitment and hepatocyte apoptosis in endotoxin-induced liver injury (2011)

  L. Nežić, L. Amidzic, V. Jaćević, S. Dobrić, R. Škrbić, M. Stojiljković, J. Komić, S. Stoisavljević-Šatara, Simvastatin improves survival and reduces leukocyte recruitment and hepatocyte apoptosis in endotoxin-induced liver injury, SCRIPTA MEDICA, Vol. 42, No. 1, pp. 7 - 13, 2011

• Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions (2012-09)

  V. Marković Peković, R. Škrbić, B. Godman, L. Gustafsson, Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions, Expert Review of Pharmacoeconomics & Outcomes Research , Vol. 12, No. 5, pp. 661 - 671, Sep, 2012

• Outpatient utilization of systemic antibiotics in the Republic of Srpska (2013-05)

  V. Marković Peković, S. Stoisavljević-Šatara, R. Škrbić, Outpatient utilization of systemic antibiotics in the Republic of Srpska, SCRIPTA MEDICA, Vol. 44, No. 1, pp. 8 - 13, May, 2013

• Severe hyperkalemia induced by propranolol (2014)

  D. Mandić, L. Nežić, R. Škrbić, Severe hyperkalemia induced by propranolol, MEDICINSKI PREGLED, Vol. 67, No. 5-6, pp. 181 - 184, 2014

• Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina (2016-05)

  V. Marković Peković, R. Škrbić, Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina, VOJNOSANITETSKI PREGLED, Vol. 73, No. 5, pp. 435 - 441, May, 2016

• Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future (2016-10)

  V. Marković Peković, R. Škrbić, A. Petrović, V. Vlahović-Palčevski, J. Mrak, M. Bennie, J. Fadare, H. Kwon, K. Schiffers, I. Truter, B. Godman, Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future, Expert Review of Pharmacoeconomics & Outcomes Research , Vol. 16, No. 5, pp. 609 - 618, Oct, 2016

• Simvastatin protects cardiomyocytes against endotoxin-induced apoptosis and up-regulates survivin/NF-kB/p65 expresion. (2018)

  L.Nežić, R.Škrbić, L.Amidžić, R. Gajanin, K. Kuča, V. Jaćević, Simvastatin protects cardiomyocytes against endotoxin-induced apoptosis and up-regulates survivin/NF-kB/p65 expresion., Scientific Reports, pp. 1 - 10, 2018

• Simvastatin Inhibits Endotoxin-Induced Apoptosis in Liver and Spleen Through Up-Regulation of Survivin/NF-κB/p65 Expression (2019-02)

  Nežić.L, L. Amidžić, R. Škrbić, R. Gajanin, E. Nepovimova, M. Vališ, K. Kuča, V. Jaćević, Simvastatin Inhibits Endotoxin-Induced Apoptosis in Liver and Spleen Through Up-Regulation of Survivin/NF-κB/p65 Expression, Frontiers in Pharmacology, pp. 1 - 13, Feb, 2019

• Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study (2019-02)

  A. Verhaz, Z. Kezić, R. Škrbić, M. Stoiljković, Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study, STED Journal, Vol. 50, No. 3, pp. 77 - 81, Feb, 2019

• Beneficial effects of pomegranate peel extract on plasma lipid profile, fatty acids level and blood pressure in patients with diabetes mellitus type-2: A randomized. double-blind, placebo-comtrolled study (2020)

  M. Grabež, R. Škrbić, M,P Stojiljković, V. Rudić-Grujić, M. Paunović, A. Arsić, S. Petrović, V. Vučić, B. Mirjanić-Azarić, K. Šavikin, N. Menković, T. Janković, N. Vasiljević, Beneficial effects of pomegranate peel extract on plasma lipid profile, fatty acids level and blood pressure in patients with diabetes mellitus type-2: A randomized. double-blind, placebo-comtrolled study, JOURNAL OF FUNCTIONAL FOODS, Vol. 64, No. 2020, pp. 103692 - 8, 2020

• Protective Effects of Simvastatin on Endotoxin-Induced Acute Kidney Injury through Activation of Tubular Epithelial Cells’ Survival and Hindering Cytochrome C-Mediated Apoptosis (2020-09)

  Lana Nežić, Rаnko Škrbić, Ljiljana Amidžić, Rаdoslav Gajanin, Zoran Milovanović, Eugenie Nepovimova, Vesna Jaćević, Kamil Kuča, Protective Effects of Simvastatin on Endotoxin-Induced Acute Kidney Injury through Activation of Tubular Epithelial Cells’ Survival and Hindering Cytochrome C-Mediated Apoptosis, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Vol. 21, No. 19, pp. 1 - 18, Sep, 2020

• Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization (2021-01)

  Suručić R, Tubić B., Stojiljković M. P., Djuric D.M, Travar M., Grabež M., Šavikin K., Škrbić R., Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization, MOLECULAR AND CELLULAR BIOCHEMISTRY, Vol. 476, No. 2, pp. 1179 - 1193, Jan, 2021